- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06234371
Financial Incentives for Veteran Therapy Completion
Financial Incentives for Therapy Completion: A Randomized Controlled Trial With U.S. Veterans
Recovery Resource Council (RRC) is one of the largest and most comprehensive non-profit mental and behavioral healthcare providers in North Texas. Accredited by the Joint Commission in Behavioral Health and licensed by the State of Texas as an Outpatient Treatment Center, RRC strives to promote wellness and recovery through a variety of services and programming. An important component of RRC programming is providing free counseling services to hundreds of U.S. veterans annually. While RRC observes great success for veterans who complete counseling, attendance can be a major obstacle.
Veterans who approach RRC for individual counseling services and consent to participate will be randomly assigned to the treatment or control group. The control group will receive counseling as usual. The treatment group will receive $500 gift card payments upon completing their 6th, 12th, and 18th counseling sessions, i.e., $1,500 in gift cards for completing all 18 sessions, the usual prescribed length of therapy. Our primary focus is to examine the impact of the financial incentives on therapy attendance and attrition. In addition, the investigators will estimate the impact on mental health using mental health inventories collected over the course of therapy sessions.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study enrollment will occur starting in September 2023 and will continue through 2026. Veterans who are referred to RRC are subject to an eligibility screening via phone, during which time they must ensure that they are 18 years of age or older, hold veteran status, are deemed not suicidal by RRC staff, and will participate in individual counseling. Eligible veterans are then assigned an intake session time, during which they show any requested documentation, complete the standard RRC intake form, complete an initial mental health assessment, and go through the informed consent process with RRC staff. Any participant who does not want to participate in the study will still receive all services as usual. After a participant gives consent, they are enrolled in the study and complete additional intake questions via the Qualtrics platform. Randomization will be done through the Qualtrics platform, so that results can be communicated to veterans immediately during their intake session. Randomization odds will be 50-50. The investigators plan to enroll 600 individuals, of which approximately 300 individuals will be offered financial incentives for therapy.
The experimental portion of these procedures is the random assignment of individuals to be offered or to not be offered financial incentives for therapy. The treatment group will be offered a $500 gift card for completing 6, 12, and 18 counseling sessions; up to $1,500 in total. Because RRC's typical practice involves prescribing and scheduling counseling in 6-session blocks, the financial awards are revealed to veterans in the treatment group in stages. After intake, treatment group individuals are told that they will receive a $500 gift card for completing the first 6 sessions; later sessions and awards are not mentioned. If the counselor decides that another 6-session block should be prescribed, then at the completion of the 5th session (i) the next 6 sessions are scheduled (i.e., sessions 7 through 12) and (ii) the counselor reveals that the participant can earn another $500 for completing the 12th session. The same process takes place during session 11. As part of RRC's typical practice, no veterans are offered more than 18 sessions. The counseling received by the control group is identical to that of the treatment group, as is the scheduling of additional sessions.
During the consent process, participants consent to be followed in administrative records. The investigators will track several outcomes of interest as they become available using several sources:
- A start-of-session mental health survey administered via Qualtrics. This survey pre-dates our study and is part of RRC's usual process.
- An end-of-session survey on expected benefits and expected costs of continuing counseling administered via Qualtrics. These questions were designed by the researchers.
- Clinical mental health screenings performed by the licensed therapists after 6, 12, and 18 sessions. The practice of collecting this information pre-dates our study and is part of RRC's usual process.
At the point that 300 individuals are enrolled in the study sample, the investigators plan to estimate the treatment effect to determine the feasibility of adding a third study arm. If the treatment effect on either average number of sessions completed or the probability of completing six sessions is sufficiently large and there is support from RRC to do so, the investigators plan to begin randomizing into a second treatment arm which will receive a gift card of value less than $500. If this third study arm becomes a reality, power calculations will be re-evaluated to shift to an updated optimal sample size.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75247
- Recovery Resource Council East Campus
-
Denton, Texas, United States, 76209
- Recovery Resource Council North Campus
-
Fort Worth, Texas, United States, 76111
- Recovery Resource Council West Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Voluntarily agree to participation requirements outlined in the informed consent form
- 18 years of age or older
- Holds veteran status
- Possesses and is willing to share SSN
- Possesses and is willing to share an active email address
- Individual is not screened out by RRC - i.e., RRC would agree to provide services independent of the research study
- Is participating in individual counseling
Exclusion Criteria:
- Individuals who are not interested in participating
- Individuals who do not consent
- Individuals posing a significant suicide risk
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment
The treatment group will be offered a $500 gift card for completing 6, 12, and 18 counseling sessions; up to $1,500 in total.
Because RRC's typical practice involves prescribing and scheduling counseling in 6-session blocks, the financial awards are revealed to veterans in the treatment group in stages.
After intake, treatment group individuals are told that they will receive a $500 gift card for completing the first 6 sessions; later sessions and awards are not mentioned.
If the counselor decides that another 6-session block should be prescribed, then at the completion of the 5th session (i) the next 6 sessions are scheduled (i.e., sessions 7 through 12) and (ii) the counselor reveals that the participant can earn another $500 for completing the 12th session.
The same process takes place during session 11.
As part of RRC's typical practice, no veterans are offered more than 18 sessions.
|
The intervention is offering a $500 gift card as an incentive for completing 6 counseling sessions to eligible individuals randomized into the treatment group.
Another $500 gift card will be given after completing 12 counseling sessions, and another $500 gift card will be given after completing 18 counseling sessions.
|
No Intervention: Control
The control group will have access to the normal counseling services provided by RRC staff.
Those in the control group will receive "business as usual" services offered by the RRC, which includes the same counseling services and evaluation of how many sessions an individual is recommended to receive.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of counseling sessions attended
Time Frame: 1 year following randomization
|
Total number of counseling sessions attended
|
1 year following randomization
|
Completion of therapy
Time Frame: 1 year following randomization
|
An indicator variable for completion of therapy will be constructed using discharge codes that RRC assigns to each patient.
In particular, there is a discharge code for program completion (regardless of the number of sessions).
|
1 year following randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Completion of every possible number of counseling sessions
Time Frame: 1 year following randomization
|
e.g., at least 1 session, at least 2 sessions, etc.
In other words, we will plot survival curves by treatment status.
|
1 year following randomization
|
Start-of-Session Mental Health Index and sub-components
Time Frame: 1 year following randomization
|
Using the responses to start-of-session questions, investigators will create a summary standardized index of mental health at the start of each session.
|
1 year following randomization
|
Expected cost and benefit of therapy
Time Frame: 1 year following randomization
|
Using the responses to survey questions asked at the end of each session regarding how a respondent thinks their symptoms will change after the next two sessions as well as how upsetting a respondent expects the next two sessions will be, investigators will create indicator variables corresponding to the categories of these expectations.
|
1 year following randomization
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Christopher Cronin, PhD, University of Notre Dame
- Principal Investigator: Ethan Lieber, PhD, University of Notre Dame
- Principal Investigator: Meghan Skira, PhD, University of Georgia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-05-6633
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Disorder
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Samsung Medical CenterUnknownMajor Depressive Disorder, Anxiety DisorderKorea, Republic of
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Repurposed Therapeutics, Inc.Unknown
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDepressive Disorder, Major Depressive DisorderUnited States
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Gangnam Severance HospitalCompletedMajor Depressive Disorder(MDD)Korea, Republic of
-
University College, LondonCompletedUnipolar Major Depressive DisorderUnited Kingdom
Clinical Trials on Financial Incentive
-
Imperial College LondonNational Health Service, United KingdomCompletedDiabetes | Diabetic Retinopathy
-
University of California, San DiegoUnited States Department of Agriculture (USDA); Latino Health Access; California... and other collaboratorsActive, not recruiting
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute, FranceUnknown
-
Harvard Pilgrim Health CareSeattle Children's HospitalCompleted
-
University of PennsylvaniaNational Institute on Aging (NIA)Completed
-
Medical College of WisconsinActive, not recruitingDiabetes Mellitus, Type 2United States
-
University of Alabama at BirminghamCenters for Disease Control and PreventionActive, not recruitingGlaucoma | Diabetic Retinopathy | Refractive Errors | Cataract | Behavior, HealthUnited States
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
University of PennsylvaniaDuke University; National Institute on Aging (NIA)Completed